ORGO

Q: What is the price of Organogenesis Holdings (ORGO) today?

The price of Organogenesis Holdings (ORGO) today is $ 2.24, with return of -48.51% compared to the last year. The price of Organogenesis Holdings (ORGO) started the year trading around $ 5.18 and today it is at $ 2.24. Follow the real-time price chart, the historical price of Organogenesis Holdings (ORGO) and international markets.

Q: When does Organogenesis Holdings (ORGO) pay dividends?

Organogenesis Holdings (ORGO) did not distribute dividends in the last year.

Q: Is Organogenesis Holdings (ORGO) worth it?

Currently, Organogenesis Holdings (ORGO) is priced at $ 2.24, with a P/E of 7.85%, representing a deviation of 15,411% from its historical average P/E. In the last year, the stock showed a variation of -48.51 in its price and distributed $ 0.00 in dividends, resulting in a Dividend Yield of 0.00%. The total shareholder return was -48.51%.It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Q: How can I buy Organogenesis Holdings (ORGO) stock?

Investing in stocks of Organogenesis Holdings (ORGO) can be done in two ways: by buying the stock abroad. The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

Q: How much would 100 shares of Organogenesis Holdings (ORGO) yield today?

The yield of Organogenesis Holdings (ORGO) was -21.95% in the last month, -48.51% in the last year and -88.70% in the last 5 years (already considering appreciation and dividends).In the last 12 months, the company paid a total of $ 0.00 in dividends, with a Dividend Yield of 0.00%.If you wanted to buy 100 stocks of Organogenesis Holdings (ORGO) today, the total investment would be $ 224.00, based on the current price of $ 2.24.If past performance were to repeat, the return on your investment would be:In 1 year: $ 115.34In 5 years: $ 25.31In 10 years: $ 224.00It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Organogenesis Holdings Inc.

Price

$ 2.24

return (12m)

-48.51%

p/e

7.85

p/bv

0.67

DIVIDEND YIELD

0.00%

ORGO price

ORGO

If you had invested

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

ago, you would now have *

ago, you would now have:

*The figure considers the reinvestment of dividends.

Return on Investment ORGO

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-21.95%

3 months

-51.67%

1 year

-48.51%

2 years

-14.18%

5 years

-88.70%

10 years

0.00%

Fundamentals ORGO

review the fundamentals of Organogenesis Holdings shares

P/E

7.85

Sector: -3.75 Industry: -3.75

P/S (PSR)

0.52

Sector: -4.18 Industry: -4.18

P/BV

0.67

Sector: 1.79 Industry: 1.79

DIVIDEND YIELD (DY)

0.00%

Sector: - Industry: -

ROA

6.19%

Sector: -62.10% Industry: -62.10%

ROE

8.54%

Sector: -62.98% Industry: -62.98%

ROIC

41.18%

Sector: -1,220.49% Industry: -1,220.49%

NET MARGIN

6.58%

Sector: -39.10% Industry: -39.10%

GROSS MARGIN

75.58%

Sector: 38.12% Industry: 38.12%

OPERATING MARGIN

9.92%

Sector: -39.31% Industry: -39.31%

EV/EBITDA

3.80

Sector: -3.57 Industry: -3.57

EV/EBIT

5.21

Sector: -3.78 Industry: -3.78

PRICE-TO-ASSETS

0.49

Sector: 1.30 Industry: 1.30

BVPS

3.42

Sector: 1.88 Industry: 1.88

EPS

0.29

Sector: -2.04 Industry: -2.04

EQUITY-TO-ASSETS RATIO

0.72

Sector: 0.42 Industry: 0.42

LIABILITIES / ASSETS

0.28

Sector: 0.39 Industry: 0.39

CAGR REVENUE 5 YEARS

3.79%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

-17.03%

Sector: - Industry: -

FAIR VALUE OF Organogenesis Holdings ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$ 2.24

Fair Value

$ 0.00

Upside/Downside Return potential.

110.89%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals ORGO

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
JNJ	21.61	7.31	33.81%	2.16%	$ 579.24 B	28.46%
PFE	19.79	1.65	8.35%	6.36%	$ 153.75 B	12.42%
ABBV	87.56	0.00	0.00%	3.18%	$ 370.01 B	6.91%
NVO	10.22	5.26	51.50%	4.68%	$ 160.05 B	33.05%
MRK	16.27	0.00	0.00%	2.74%	$ 296.92 B	28.08%
AZN	28.58	6.00	20.99%	1.70%	$ 292.24 B	17.41%
GILD	19.48	7.33	37.62%	2.39%	$ 165.80 B	28.90%
BMY	16.90	-3.50	-20.72%	4.25%	$ 119.19 B	14.64%
ZTS	18.57	14.90	80.25%	1.79%	$ 49.65 B	28.23%
REGN	16.87	2.43	14.41%	0.49%	$ 75.98 B	31.41%
HALO	22.95	148.99	649.21%	0.00%	$ 7.27 B	22.69%
AMGN	24.38	21.71	89.06%	2.77%	$ 187.99 B	20.98%
MCK	24.38	-1,068.68	-4,383.84%	0.36%	$ 105.80 B	1.09%
VRTX	27.83	5.89	21.18%	0.00%	$ 110.00 B	32.94%
CAH	29.33	-18.06	-61.56%	0.99%	$ 48.75 B	0.68%
ADMA	14.98	4.61	30.78%	0.00%	$ 2.20 B	28.80%
BIIB	20.90	1.48	7.08%	0.00%	$ 27.02 B	13.07%
HRMY	9.53	1.74	18.24%	0.00%	$ 1.51 B	18.27%

Stock vs Indice Comparison Tool

If you had invested (change) 2 years years ago, ago, you would now have

R$ 1.000,00 in PETR4 You would now have R$ 2.294,60

R$ 1.000,00 in LEVE3 You would now have R$ 5.240,60

*The value considers the reinvestment of dividends.

ORGO Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Organogenesis Holdings

Organogenesis Holdings Inc.

Average Investor10 user rating

4.0 (1 people)

United States

11 years

Founded: 2015

2016

Time since IPO - 10 years

910

Employees

The Company Organogenesis Holdings Inc. (United States), is listed on Nasdaq with a market value of $ 290.83 Millions, having an equity of $ 433.92 Millions.

With a total of 910 employees, the company is listed in the sector of Health Care and categorized in industry of Biotechnology.

In the last 12 months the Company had a revenue of $ 563.03 Millions, which generated a profit in the amount of $ 37.04 Millions.

As for its main indicators, the Company has a P/E ratio of 7.85, a P/BV ratio of 0.67 and in the last 12 months the Company did not pay dividends.

The Company is traded internationally through the ticker ORGO.

Market cap

$ 290.83 Millions

Net worth

$ 433.92 Millions

US$ 433,920,000.00

Assets

$ 598.73 Millions

US$ 598,730,000.00

Total Shares Outstanding

127.00 Millions

127,000,000

Average Daily Trading Volume

$ 661.57 Thousand

US$ 661,568.92

Sector

Health Care

Industry

Biotechnology

ORGO

ORGO revenue and profits

Financial Results ORGO

DRAG THE FRAME TO SEE MORE DATA

ORGO cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

BFRA - Biofrontera

$ - -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$ 884.28 23,83% (12M)

P/E

24.38

0.36%

ROE

-4,383.84%

P/BV

-1,068.68

CAH - Cardinal Health

$ 214.05 58,49% (12M)

P/E

29.33

0.99%

ROE

-61.56%

P/BV

-18.06

JNJ - Johnson & Johnson

$ 243.04 56,31% (12M)

P/E

21.61

2.16%

ROE

33.81%

P/BV

7.31

PFE - Pfizer

$ 28.32 25,05% (12M)

P/E

19.79

6.36%

ROE

8.35%

P/BV

1.65

ABBV - AbbVie

$ 208.84 7,85% (12M)

P/E

87.56

3.18%

ROE

0.00%

P/BV

0.00

MRK - Merck & Co.

$ 120.87 46,25% (12M)

P/E

16.27

2.74%

ROE

0.00%

P/BV

0.00

AZN - AstraZeneca

$ 203.49 51,28% (12M)

P/E

28.58

1.70%

ROE

20.99%

P/BV

6.00

BFRA - Biofrontera

$ - -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$ 884.28 23,83% (12 M)

P/L

24.38

0.36%

ROE

-4,383.84%

P/VP

-1,068.68

CAH - Cardinal Health

$ 214.05 58,49% (12 M)

P/L

29.33

0.99%

ROE

-61.56%

P/VP

-18.06

JNJ - Johnson & Johnson

$ 243.04 56,31% (12 M)

P/L

21.61

2.16%

ROE

33.81%

P/VP

7.31

PFE - Pfizer

$ 28.32 25,05% (12 M)

P/L

19.79

6.36%

ROE

8.35%

P/VP

1.65

ABBV - AbbVie

$ 208.84 7,85% (12 M)

P/L

87.56

3.18%

ROE

0.00%

P/VP

0.00

MRK - Merck & Co.

$ 120.87 46,25% (12 M)

P/L

16.27

2.74%

ROE

0.00%

P/VP

0.00

AZN - AstraZeneca

$ 203.49 51,28% (12 M)

P/L

28.58

1.70%

ROE

20.99%

P/VP

6.00

Frequently Asked Questions

What is the price of Organogenesis Holdings (ORGO) today?

The price of Organogenesis Holdings (ORGO) today is $ 2.24, with return of -48.51% compared to the last year. The price of Organogenesis Holdings (ORGO) started the year trading around $ 5.18 and today it is at $ 2.24. Follow the real-time price chart, the historical price of Organogenesis Holdings (ORGO) and international markets.

When does Organogenesis Holdings (ORGO) pay dividends?

Organogenesis Holdings (ORGO) did not distribute dividends in the last year.

Is Organogenesis Holdings (ORGO) worth it?

Currently, Organogenesis Holdings (ORGO) is priced at $ 2.24, with a P/E of 7.85%, representing a deviation of 15,411% from its historical average P/E. In the last year, the stock showed a variation of -48.51 in its price and distributed $ 0.00 in dividends, resulting in a Dividend Yield of 0.00%. The total shareholder return was -48.51%.

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

How can I buy Organogenesis Holdings (ORGO) stock?

Investing in stocks of Organogenesis Holdings (ORGO) can be done in two ways: by buying the stock abroad. The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.

BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

How much would 100 shares of Organogenesis Holdings (ORGO) yield today?

The yield of Organogenesis Holdings (ORGO) was -21.95% in the last month, -48.51% in the last year and -88.70% in the last 5 years (already considering appreciation and dividends).

In the last 12 months, the company paid a total of $ 0.00 in dividends, with a Dividend Yield of 0.00%.

If you wanted to buy 100 stocks of Organogenesis Holdings (ORGO) today, the total investment would be $ 224.00, based on the current price of $ 2.24.

If past performance were to repeat, the return on your investment would be:

In 1 year: $ 115.34
In 5 years: $ 25.31
In 10 years: $ 224.00

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

ORGO

Organogenesis Holdings Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment ORGO

review the fundamentals of Organogenesis Holdings shares

P/E

P/S (PSR)

P/BV

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

EV/EBITDA

EV/EBIT

PRICE-TO-ASSETS

BVPS

EPS

EQUITY-TO-ASSETS RATIO

LIABILITIES / ASSETS

CAGR REVENUE 5 YEARS

CAGR PROFIT 5 YEARS

Graham's Fair Value

If you had invested (change) 2 years years ago, ago, you would now have

current DY: 0.00%

5-year average DY: 0.00%

ABOUT Organogenesis Holdings

Organogenesis Holdings Inc.

United States

11 years

2016

910

PROFIT X PRICE ORGO

Financial Results ORGO

ORGO cash flow

Asset, Revenue and Profit Growth - ORGO

ORGO balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

PFE - Pfizer

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

PFE - Pfizer

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

Frequently Asked Questions